Browsing the "CASMI Views" Category

Podcast: Reaching a Personalized Medicine Milestone

non-slider CASMI_graphic_9

With the recent news that Illumina’s latest sequencers have broken the $1,000 genome barrier, there’s great anticipation about the acceleration of personalized medicine. The Burrill Report spoke to Ed Abrahams, president of the Personalized Medicine Coalition, about the significance of the milestone, the move of whole genome sequencing to the [...]

February 4, 2014 Andrea Hodgetts CASMI Views 0

Tufts study: Data suggest breakthrough therapy designation meets goals


Nearly 18 months after its launch by the FDA, the breakthrough therapy designation (BTD) is showing the potential to meet the agency’s stated goal of speeding the development and review of drugs that show early evidence of offering substantial improvement over existing therapies on a clinically significant endpoint. By approving [...]

February 4, 2014 Andrea Hodgetts CASMI Views 0

Podcast: Pharma Faces Shrinking Returns from Innovation

burril report

The biggest pharmaceutical companies are successfully bringing new products to market, but are struggling with diminishing returns on investment, according to a new report from Deloitte and Thomson Reuters. The Burrill Report spoke to Neil Lesser, principal of life sciences strategy for Deloitte, about the industry’s efforts to remake R&D, [...]

December 11, 2013 Andrea Hodgetts CASMI Views 0

FDA on Personalised Medicine

BioCentuary Personalised Medicine

Stratified Medicine (personalising treatments to distinct patient populations) is the topic of this week’s BioCentury videocast. The FDA recently approved Illumina’s Next Generation Sequencing Technology, which rapidly and affordably sequences a patient’s genome, allowing doctors to make tailored treatment decisions after a single test. Following this decision, FDA Commissioner Margaret [...]

November 25, 2013 Andrea Hodgetts CASMI Views 0

Cut EU Red Tape: Report from the Business Taskforce

cut EU red tape slider

CASMI contributed to the latest report from the Business Taskforce written for British Government, which calls for cutting red tape in clinical trials and making flexibilities in licensing more visible. This is particularly relevant for our Adaptive Licensing project, which uses existing legislation to grant patients earlier access to new medicines, [...]

October 17, 2013 Andrea Hodgetts CASMI Views 0

WEBCAST: The Current State of Biomedical Innovation

Screen Shot 2013-09-03 at 12.20.22

Summary from the Brookings Institution: On July 16, the Engelberg Center for Health Care Reform at Brookings hosted the second annual State of Biomedical Innovation conference. The goal of this conference was to assess U.S. biomedical innovation and discuss policy solutions that ensure the nation remains a world leader. This year, the conference [...]

September 3, 2013 Andrea Hodgetts CASMI Views 0

VIDEO: “The answer is not to stop innovating but to innovate better” – Sir John Tooke

JT Speech


August 27, 2013 Andrea Hodgetts CASMI Views 0

VIDEO: “You can’t just drop innovation into a system that doesn’t work” says Sir John Bell

JB Speech


August 12, 2013 Andrea Hodgetts CASMI Views 0

The Dragon’s Clinic

non-slider CASMI_graphic_9

CASMI Fellow Nick Edwards acts as a ‘Dragon’ as Oxford medical students present their innovative business ideas to a panel of judges: [...]

June 5, 2013 Andrea Hodgetts CASMI Views 0

Nick Edwards Blogs about Creating the Oxford AHSN

slider CASMI_graphic_10

“I am currently working on the development of the Oxford Academic Health Sciences Network which will bring together the NHS, universities and businesses to promote medical innovation to improve patient care and promote wealth creation.  One of 15 AHSNs that will cover all of England, the Oxford one covers Oxfordshire, [...]

May 10, 2013 Andrea Hodgetts CASMI Views 0